BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2122563)

  • 1. G protein activation: a receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides.
    Mousli M; Bueb JL; Bronner C; Rouot B; Landry Y
    Trends Pharmacol Sci; 1990 Sep; 11(9):358-62. PubMed ID: 2122563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catestatin (CgA344-364) stimulates rat mast cell release of histamine in a manner comparable to mastoparan and other cationic charged neuropeptides.
    Krüger PG; Mahata SK; Helle KB
    Regul Pept; 2003 Jun; 114(1):29-35. PubMed ID: 12763637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Gi-like proteins, a receptor-independent effect of kinins in mast cells.
    Bueb JL; Mousli M; Bronner C; Rouot B; Landry Y
    Mol Pharmacol; 1990 Dec; 38(6):816-22. PubMed ID: 1701214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human and rat cutaneous mast cells: involvement of a G protein in the response to peptidergic stimuli.
    Emadi-Khiav B; Mousli M; Bronner C; Landry Y
    Eur J Pharmacol; 1995 Jan; 272(1):97-102. PubMed ID: 7536161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptidergic pathway in human skin and rat peritoneal mast cell activation.
    Mousli M; Hugli TE; Landry Y; Bronner C
    Immunopharmacology; 1994; 27(1):1-11. PubMed ID: 7515863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of rat peritoneal mast cells by substance P and mastoparan.
    Mousli M; Bronner C; Bueb JL; Tschirhart E; Gies JP; Landry Y
    J Pharmacol Exp Ther; 1989 Jul; 250(1):329-35. PubMed ID: 2473189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mastoparan promotes exocytosis and increases intracellular cyclic AMP in human platelets. Evidence for the existence of a Ge-like mechanism of secretion.
    Wheeler-Jones CP; Saermark T; Kakkar VV; Authi KS
    Biochem J; 1992 Jan; 281 ( Pt 2)(Pt 2):465-72. PubMed ID: 1310599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin releasing effects of mastoparan and amphiphilic substance P receptor antagonists on RINm5F insulinoma cells.
    Hillaire-Buys D; Mousli M; Landry Y; Bockaert J; Fehrentsz JA; Carrette J; Rouot B
    Mol Cell Biochem; 1992 Feb; 109(2):133-8. PubMed ID: 1378173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exocytosis in chromaffin cells: evidence for a MgATP-independent step that requires a pertussis toxin-sensitive GTP-binding protein.
    Vitale N; Thiersé D; Aunis D; Bader MF
    Biochem J; 1994 May; 300 ( Pt 1)(Pt 1):217-27. PubMed ID: 8198537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mastoparan analog without lytic effects and its stimulatory mechanisms in mast cells.
    Mukai H; Kikuchi M; Suzuki Y; Munekata E
    Biochem Biophys Res Commun; 2007 Oct; 362(1):51-55. PubMed ID: 17692824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of substance P, compound 48/80 and mastoparan with the alpha-subunit C-terminus of G protein.
    Mousli M; Bronner C; Bockaert J; Rouot B; Landry Y
    Immunol Lett; 1990 Sep; 25(4):355-7. PubMed ID: 1701162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the amphiphilic peptides mastoparan and adenoregulin on receptor binding, G proteins, phosphoinositide breakdown, cyclic AMP generation, and calcium influx.
    Shin Y; Moni RW; Lueders JE; Daly JW
    Cell Mol Neurobiol; 1994 Apr; 14(2):133-57. PubMed ID: 7842473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pertussis toxin-insensitive effects of mastoparan, a wasp venom peptide, in PC12 cells.
    Murayama T; Oda H; Nomura Y
    J Cell Physiol; 1996 Dec; 169(3):448-54. PubMed ID: 8952694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mastoparan, a wasp venom peptide, identifies two discrete mechanisms for elevating cytosolic calcium and inositol trisphosphates in human polymorphonuclear leukocytes.
    Perianin A; Snyderman R
    J Immunol; 1989 Sep; 143(5):1669-73. PubMed ID: 2760463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agmatine: a mastoparan-like activity related to direct activation of heterotrimeric G proteins.
    Ferry X; Landry Y
    Eur J Pharmacol; 2002 Jan; 435(1):19-26. PubMed ID: 11790374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G-proteins as targets for non-immunological histamine releasers.
    Mousli M; Bueb JL; Rouot B; Landry Y; Bronner C
    Agents Actions; 1991 May; 33(1-2):81-3. PubMed ID: 1716843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mastoparan may activate GTP hydrolysis by Gi-proteins in HL-60 membranes indirectly through interaction with nucleoside diphosphate kinase.
    Klinker JF; Hagelüken A; Grünbaum L; Heilmann I; Nürnberg B; Harhammer R; Offermanns S; Schwaner I; Ervens J; Wenzel-Seifert K
    Biochem J; 1994 Dec; 304 ( Pt 2)(Pt 2):377-83. PubMed ID: 7998971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of GTPase activity of recombinant G(o) alpha by peptides representing sequence permutations of mastoparan.
    Oppi C; Wagner T; Crisari A; Camerini B; Tocchini Valentini GP
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8268-72. PubMed ID: 1518856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elucidation of structural requirements of mastoparan for mast cell activation-toward the comprehensive prediction of cryptides acting on mast cells.
    Mukai H; Suzuki Y; Kiso Y; Munekata E
    Protein Pept Lett; 2008; 15(9):931-7. PubMed ID: 18991769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exocytosis in mast cells by basic secretagogues: evidence for direct activation of GTP-binding proteins.
    Aridor M; Traub LM; Sagi-Eisenberg R
    J Cell Biol; 1990 Sep; 111(3):909-17. PubMed ID: 1697300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.